|
|
Volumn 289, Issue 12, 2003, Pages 1491-
|
|
Critics Bash HIV Vaccine Trial Analysis
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
GLYCOPROTEIN GP 120;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG RESEARCH;
FOOD AND DRUG ADMINISTRATION;
HUMAN IMMUNODEFICIENCY VIRUS;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
INFECTION RISK;
PRIORITY JOURNAL;
REVIEW;
VACCINATION;
ARTICLE;
CONTROLLED CLINICAL TRIAL;
HUMAN;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
AIDS VACCINES;
CLINICAL TRIALS, PHASE III;
HIV ENVELOPE PROTEIN GP120;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
|
|
EID: 0344160901
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.289.12.1491 Document Type: Review |
|
Times cited : (7)
|
|
References (0)
|